Applied DNA Sciences Inc (APDN) PT Set at $6.00 by Maxim Group

Applied DNA Sciences Inc (OTCMKTS:APDN) received a $6.00 price objective from research analysts at Maxim Group in a research note issued on Tuesday, June 27th. The brokerage currently has a “buy” rating on the technology company’s stock. Maxim Group’s price target would suggest a potential upside of 275.00% from the company’s previous close.

Separately, ValuEngine downgraded Applied DNA Sciences from a “sell” rating to a “strong sell” rating in a research report on Friday, June 2nd.

Shares of Applied DNA Sciences (OTCMKTS:APDN) traded down 1.23% during midday trading on Tuesday, reaching $1.60. 50,377 shares of the company’s stock traded hands. The firm’s market cap is $42.16 million. Applied DNA Sciences has a 52-week low of $0.90 and a 52-week high of $3.61. The company has a 50 day moving average of $1.42 and a 200 day moving average of $1.63.

Applied DNA Sciences (OTCMKTS:APDN) last announced its quarterly earnings data on Thursday, May 11th. The technology company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.01. Applied DNA Sciences had a negative net margin of 378.72% and a negative return on equity of 128.10%. The business had revenue of $0.91 million during the quarter, compared to analyst estimates of $1.25 million. During the same period last year, the firm posted ($0.14) EPS. The company’s revenue was up 59.6% on a year-over-year basis. On average, equities analysts predict that Applied DNA Sciences will post ($0.39) EPS for the current fiscal year.

WARNING: This story was originally posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

Receive News & Ratings for Applied DNA Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences Inc and related companies with's FREE daily email newsletter.

Leave a Reply